BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3439374)

  • 1. [Prognostic significance of dysplastic urothelial changes for the rate of recurrence in superficial urinary bladder cancer].
    Flamm J
    Z Urol Nephrol; 1987 Nov; 80(11):641-6. PubMed ID: 3439374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dysplastic urothelial changes in patients with bladder cancer].
    Csapó Z; Kolozsy Z; Dauda G; Mohácsi L
    Urologe A; 1984 Sep; 23(5):281-4. PubMed ID: 6542270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
    Jancke G; Damm O; Rosell J; Jahnson S
    Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [DNA profile, recurrence rate and progression of superficial G2 cancer of the urinary bladder].
    Maier G; Heissler HE; Blech M; Schröter W
    Urologe A; 1988 May; 27(3):173-6. PubMed ID: 3407050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of local tumor associated infiltration of mononuclear leukocytes for persistent tumor formations following transurethral resection (TUR) of bladder cancers].
    Flamm J
    Z Urol Nephrol; 1985 Feb; 78(2):65-70. PubMed ID: 3993242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of random biopsies of healthy mucosa in superficial bladder tumor].
    Fernández Gómez JM; Rodríguez Martínez JJ; Escaf Barmadah S; Pérez García J; García J; Casasola Chamorro J
    Arch Esp Urol; 2000 Nov; 53(9):785-97. PubMed ID: 11196385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dedifferentiated superficial bladder cancer with invasion of the lamina propria (pT1 GIII)].
    Flamm J
    Z Urol Nephrol; 1986 Sep; 79(9):511-6. PubMed ID: 3788301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urothelial bladder biopsy--important evolution prognosis factor of superficial bladder cancer under intravesical Bacille Calmette-Guérin therapy.
    Geavlete P; Taşcă C
    Rom J Morphol Embryol; 1991; 37(1-2):61-8. PubMed ID: 1801981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of the proliferation status (PCNA) and p53 immunohistochemistry as a prognostic factor for the clinical course of superficial cancer of the urinary bladder].
    Kuczyk MA; Serth J; Bokemeyer C; Hervatin C; Oelke M; Oelert F; Höfner K; Jonas U
    Urologe A; 1995 Mar; 34(2):146-52. PubMed ID: 7754587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on multiple mucosal biopsy in patients with bladder cancer. 3. Evaluation of ABH antigenicity in specimens of multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1649-62. PubMed ID: 3825814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.
    Li CC; Chang TH; Wu WJ; Ke HL; Huang SP; Tsai PC; Chang SJ; Shen JT; Chou YH; Huang CH
    Eur Urol; 2008 Nov; 54(5):1127-34. PubMed ID: 18243511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Iatrogenic tumor cell implantation in bladder cancer].
    Mack D; Rammal E; Jakse G
    Urologe A; 1988 Mar; 27(2):99-104. PubMed ID: 3376373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cancerous and precancerous changes in the tumor margin areas of patients with bladder cancers].
    Blume B; Theuring F
    Z Urol Nephrol; 1985 Feb; 78(2):71-6. PubMed ID: 3993243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder.
    Elsamman E; Fukumori T; Kasai T; Nakatsuji H; Nishitani MA; Toida K; Ali N; Kanayama HO
    BJU Int; 2006 Jun; 97(6):1202-7. PubMed ID: 16686711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of recurrence in urinary bladder tumors by intravesical instillation treatment with adriamycin].
    Flamm J; Grof F
    Urologe A; 1985 Jan; 24(1):31-5. PubMed ID: 4039083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nucleolar organizers in superficial bladder tumors. Prognostic analysis of 37 observations].
    Clement T; Visseaux-Coletto B; Adnet JJ; Ploton D; Lardennois B
    Prog Urol; 1991 Apr; 1(2):216-29. PubMed ID: 1844824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal high-polysomies predict tumour progression in T1 transitional cell carcinoma of the bladder.
    Ribal MJ; Alcaraz A; Mengual L; Carrio A; Lopez-Guillermo A; Mallofré C; Palou J; Gelabert A; Villavicencio H
    Eur Urol; 2004 May; 45(5):593-9. PubMed ID: 15082201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.